ACOG recommendations include 3 biomarker assays to assess risk for these cancer subtypes: Alpha-fetoprotein (AFP), Human chorionic gonadotropin (β-HCG), and Lactic dehydrogenase (LDH). The gene discussed is AFP; the disease is cancer.